Jung Melita Sun 4
4 · Terns Pharmaceuticals, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Jung Melita Sun
Chief Business Officer
Transactions
- Purchase
Common Stock
2024-11-30$5.11/sh+2,250$11,498→ 2,250 total - Award
Stock Option (Right to Buy)
2025-01-30+325,000→ 325,000 totalExercise: $4.64Exp: 2035-01-29→ Common Stock (325,000 underlying)
Footnotes (2)
- [F1]Includes 2,250 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2024.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.